Literature DB >> 31669646

TNF-α/miR-155 axis induces the transformation of osteosarcoma cancer stem cells independent of TP53INP1.

Jinzhi Yao1, Jianguang Lin2, Lijiang He1, Jiemiao Huang1, Qiaoling Liu3.   

Abstract

MicroRNA-155 (miR-155) has been identified to be overexpressed in various human cancers including osteosarcoma. However, whether the up-regulation of miR-155 is associated with osteosarcoma cancer stem cells (CSCs) is not well understood. In the present study, we showed that miR-155 induced the acquisition of stem-like features in U2OS osteosarcoma cells by increasing the expression of both CSCs surface markers (CD24, CD90, CD133) and CSC-related transcriptional factors (Nanog, SOX2, Oct4, Bim-1). Inflammatory factor TNF-α upregulated the miR-155 expression in U2OS cells and formed a feedback regulatory loop with miR-155. Furthermore, TNF-α/miR-155 axis promoted the cell proliferation, invasion and epithelial-mesenchymal transition (EMT) process in a TP53INP1 independent manner. We also revealed that TNF-α/miR-155 axis induced osteosarcoma CSCs transformation via ERK signaling pathway. These results indicate a crucial role of miR-155 in the acquisition of osteosarcoma CSC phenotype and miR-155 may serve as a potential target in future osteosarcoma therapy.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EMT; MiR-155; Osteosarcoma; TNF-α; TP53INP1

Mesh:

Substances:

Year:  2019        PMID: 31669646     DOI: 10.1016/j.gene.2019.144224

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

1.  MicroRNA-133a-Dependent Inhibition of Proximal Tubule Angiotensinogen by Renal TNF (Tumor Necrosis Factor).

Authors:  Shoujin Hao; Joseph Salzo; Hong Zhao; Mary Hao; Zbigniew Darzynkiewicz; Nicholas R Ferreri
Journal:  Hypertension       Date:  2020-11-02       Impact factor: 10.190

Review 2.  The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment.

Authors:  Dipranjan Laha; Robert Grant; Prachi Mishra; Naris Nilubol
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

3.  Efficacy of ifosfamide combined with liposome doxorubicin on osteosarcoma and its effects on serum IL-10, TNF-α, and IFN-γ in patients with osteosarcoma.

Authors:  Guilin Huang; Sha Hua; Heming Liu; Haizhen Zhou; Xiujin Chen; Zhichou Wang; Wenxing Yu
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

Review 4.  MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.

Authors:  Adriana Fodor; Andrada Luciana Lazar; Cristina Buchman; Brandusa Tiperciuc; Olga Hilda Orasan; Angela Cozma
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

Review 5.  Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma.

Authors:  Camille Jubelin; Javier Muñoz-Garcia; Denis Cochonneau; Emilie Moranton; Marie-Françoise Heymann; Dominique Heymann
Journal:  Cancer Drug Resist       Date:  2022-02-16

Review 6.  Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies.

Authors:  Daniel L Pouliquen; Alice Boissard; Cécile Henry; Olivier Coqueret; Catherine Guette
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

Review 7.  Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters.

Authors:  Sara R Martins-Neves; Gabriela Sampaio-Ribeiro; Célia M F Gomes
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

Review 8.  HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development.

Authors:  Devis Pascut; Minh Hoang; Nhu N Q Nguyen; Muhammad Yogi Pratama; Claudio Tiribelli
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

Review 9.  Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers.

Authors:  Guillaume Anthony Odri; Joëlle Tchicaya-Bouanga; Diane Ji Yun Yoon; Dominique Modrowski
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

10.  Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma.

Authors:  Riyu Chen; Zeyi Guan; Xianxing Zhong; Wenzheng Zhang; Ya Zhang
Journal:  Comput Math Methods Med       Date:  2022-01-13       Impact factor: 2.238

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.